february, 2019

06feb1:00 PM2:00 PM2019 Life Science Predictions: Decoding 5 Incredible Growth OpportunitiesONLINE | Virtual Clinical Trials, Cell & Gene Therapies, DTC Testing, Liquid Biopsy, and IVF Services Spur Multi-billion Dollar BusinessesWebinarCategory:Growth Opportunity Briefings

Life Sciences Market


(Wednesday) 1:00 PM - 2:00 PM



7550 1H, 10 W Dr Suite 400

Event Details

The Life Science industry is in a state of flux. While recent years have seen the advent of multiple novel technologies—such as IVF, CRISPR-Cas9, virtual clinical trials, and liquid biopsy—the industry today stands at a crossroads with challenges in scaling up and commercializing such technologies. The industry has now come to terms with new, path-breaking life science technologies that are helping make precision healthcare a reality. Chinese investments into the US biopharma industry jumped to $4.5 billion in 2018. An exclusive fireside chat with our US and China analysts will uncover trends in cross-border investments and growth opportunities in these two markets.

Key Takeaways:

  • Establish the leading factors that will influence the size and direction of the global life sciences market in 2019.
  • Build clarity on technology developments in the global life sciences market in 2018 that will have an impact during 2019.
  • Identify the business models used to commercialize and distribute novel life science solutions.
  • Discover the key growth opportunities and strategic imperatives for companies in 2019.


Frost & Sullivaninfo@frost.com 7550 1H, 10 W Dr #400, San Antonio, TX 78229